InterventionsHuman trial

First Report on the Small Molecule Oral GLP-1 Receptor Agonist RGT-075 in Obesity—A Randomized, Placebo-Controlled Phase 2a Proof-of-Concept Twelve-Week Study

ADA Scientific Sessions 2025 Abstract

The paper

ROSENSTOCK J, LENDER D, RAISER F et al.

ADA Scientific Sessions 2025 Abstract · 13 Jun 2025

Presented at ADA Scientific Sessions 2025 · Poster 785-P

doi.org/10.2337/db25-785-p

Related